1. A Preliminary Assessment of the Benefits of the Addition of Botulinum Toxin A to a Conventional Therapy Program on the Function of People With Longstanding Stroke 
Jay M. Meythaler, MD, JD, Laura Vogtle, PhD, Robert C. Brunner, MD 
Archives of Physical Medicine and Rehabilitation 
Volume 90, Issue 9, Pages (September 2009)
DOI: /j.apmr
Copyright © 2009 American Congress of Rehabilitation Medicine Terms and Conditions

2. Fig 1 The CONSORT diagram.
Archives of Physical Medicine and Rehabilitation  , DOI: ( /j.apmr )
Copyright © 2009 American Congress of Rehabilitation Medicine Terms and Conditions

3. Fig 2
The mean MAL with standard deviation bars or AOU presented individually for both group 1 BTX-A/drug followed by placebo and group 2 placebo followed by BTX-A at baseline and the end of each 12-week arm.
Archives of Physical Medicine and Rehabilitation  , DOI: ( /j.apmr )
Copyright © 2009 American Congress of Rehabilitation Medicine Terms and Conditions

4. Fig 3
The mean MAL with standard deviation bars for QOM presented individually for both group 1 BTX-A/drug followed by placebo and group 2 placebo followed by BTX-A at baseline and the end of each 12-week arm.
Archives of Physical Medicine and Rehabilitation  , DOI: ( /j.apmr )
Copyright © 2009 American Congress of Rehabilitation Medicine Terms and Conditions